Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2017 4
2018 5
2019 6
2020 3
2021 9
2022 12
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors.
Chen S, Petricca J, Ye W, Guan J, Zeng Y, Cheng N, Gong L, Shen SY, Hua JT, Crumbaker M, Fraser M, Liu S, Bratman SV, van der Kwast T, Pugh T, Joshua AM, De Carvalho DD, Chi KN, Awadalla P, Ji G, Feng F, Wyatt AW, He HH. Chen S, et al. Among authors: crumbaker m. Nat Commun. 2022 Oct 29;13(1):6467. doi: 10.1038/s41467-022-34012-2. Nat Commun. 2022. PMID: 36309516 Free PMC article.
AR Signaling and the PI3K Pathway in Prostate Cancer.
Crumbaker M, Khoja L, Joshua AM. Crumbaker M, et al. Cancers (Basel). 2017 Apr 15;9(4):34. doi: 10.3390/cancers9040034. Cancers (Basel). 2017. PMID: 28420128 Free PMC article. Review.
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.
Joshua AM, Armstrong A, Crumbaker M, Scher HI, de Bono J, Tombal B, Hussain M, Sternberg CN, Gillessen S, Carles J, Fizazi K, Lin P, Duggan W, Sugg J, Russell D, Beer TM. Joshua AM, et al. Among authors: crumbaker m. Eur J Cancer. 2022 Jul;170:285-295. doi: 10.1016/j.ejca.2022.04.005. Epub 2022 May 26. Eur J Cancer. 2022. PMID: 35643841 Free PMC article.
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue.
Nguyen LT, Lo CS, Fyrsta M, Nie J, Yam JY, Yen PH, Le MX, Hersey K, Kenk M, Crumbaker M, Fleshner N, Kulkarni G, Hamilton R, Jewett M, Finelli A, Evans A, Sweet J, Ohashi PS, Joshua AM. Nguyen LT, et al. Among authors: crumbaker m. Prostate Cancer. 2022 Jun 16;2022:6499344. doi: 10.1155/2022/6499344. eCollection 2022. Prostate Cancer. 2022. PMID: 35754788 Free PMC article.
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT).
Emmett L, John N, Pathmanandavel S, Counter W, Ayers M, Sharma S, Agrawal S, Poole A, Hovey E, Pranavan G, Gedye C, Mallesara G, Guminski A, Lee A, Stockler MR, Hickey A, Eu P, Joshua AM, Crumbaker M, Nguyen A. Emmett L, et al. Among authors: crumbaker m. Ther Adv Med Oncol. 2023 Mar 1;15:17588359231156392. doi: 10.1177/17588359231156392. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36872949 Free PMC article.
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
Mak B, Lin HM, Kwan EM, Fettke H, Tran B, Davis ID, Mahon K, Stockler MR, Briscoe K, Marx G, Zhang A, Crumbaker M, Tan W, Huynh K, Meikle TG, Mellett NA, Hoy AJ, Du P, Yu J, Jia S, Joshua AM, Waugh DJ, Butler LM, Kohli M, Meikle PJ, Azad AA, Horvath LG. Mak B, et al. Among authors: crumbaker m. BMC Med. 2022 Mar 25;20(1):112. doi: 10.1186/s12916-022-02298-0. BMC Med. 2022. PMID: 35331214 Free PMC article.
35 results